Contact Us: 01282 426380
KM Financial Solutions | Britain says Canada’s Concordia overcharging health service for thyroid drug
3902
post-template-default,single,single-post,postid-3902,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Britain says Canada’s Concordia overcharging health service for thyroid drug

20 Nov Britain says Canada’s Concordia overcharging health service for thyroid drug

Posted at 09:47h in News by
0 Likes
LONDON, Nov 21 (Reuters) – Drug company Concordia
overcharged Britain’s health service millions of pounds for an
essential thyroid drug by abusing its position as the only
supplier, the country’s Competition and Markets Authority said
on Tuesday.

No Comments

Post A Comment